Status:
NOT_YET_RECRUITING
The Effect of a Stepped-care Metacognition-based Intervention on Managing Fear of Cancer Recurrence
Lead Sponsor:
The University of Hong Kong
Conditions:
Cancer
Fear of Cancer Recurrence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A sequential multiple-assignment randomized controlled trial (SMART) will be used to assess the effect of an adaptive stepped-care intervention on FCR in cancer survivors with subclinical levels of fe...
Detailed Description
The current SMART trial aims to address the following hypotheses: Hypothesis 1: It is better to begin adaptive interventions with eConquerFear than with eHealthMaintenance. Hypothesis 2: Among initi...
Eligibility Criteria
Inclusion
- Cantonese- or Mandarin-speaking Chinese patients diagnosed with curable breast, colorectal, or gynecological cancer, who had completed treatment (except endocrine therapy) within five years, and with a Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF) score of 13 to 21 indicating subclinical FCR will be included.
Exclusion
- Patients with metastatic cancer, with a current diagnosis of depression or psychosis, or who are already receiving psychological treatment will be excluded.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06181331
Start Date
January 1 2026
End Date
December 31 2027
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QMh department of surgery
Hong Kong, Hong Kong